Navidea生物制药(NAVB)

1.6299 -0.0501 -2.9821%

今开:1.73昨收:1.68
最高:1.73 最低:1.62
涨停价:0.0跌停价:0.0
总市值:4.9147098E7

Navidea生物制药的热门评论

Navidea生物制药(NAVB)05-14 04:12

$Navidea生物制药(NAVB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-012043 Act: 34 Size: 5 MB 网页链接查看全文

Navidea生物制药(NAVB)05-14 04:45

$Navidea生物制药(NAVB)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001437749-21-012089 Act: 33 Size: 391 KB 网页链接查看全文

Navidea生物制药(NAVB)05-12 04:42

$Navidea生物制药(NAVB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-21-011697 Act: 34 Size: 100 KB 网页链接查看全文

Navidea生物制药(NAVB)05-12 04:18

$Navidea生物制药(NAVB)$ 8-K Current report, item 5.02 Accession Number: 0001437749-21-011698 Act: 34 Size: 20 KB 网页链接查看全文

Navidea生物制药(NAVB)2020-09-03 05:06

$Navidea生物制药(NAVB)$ 8-K Current report, items 1.01, 5.03, and 9.01 Accession Number: 0001437749-20-019237 Act: 34 Size: 448 KB 网页链接查看全文

股东委托书协议

Navidea生物制药(NAVB)08-02 19:36

$Navidea生物制药(NAVB)$ DEF 14A Other definitive proxy statements Accession Number: 0001437749-21-018064 Act: 34 Size: 626 KB 网页链接查看全文

Navidea生物制药(NAVB)07-27 07:33

$Navidea生物制药(NAVB)$ 内部交易: 2021-07-26,Director,Witter Malcolm G ,买入,15000普通股, $1.70查看全文

持股变动声明

Navidea生物制药(NAVB)07-27 21:03

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-017568 Size: 4 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Navidea生物制药的最新评论

股东委托书协议

Navidea生物制药(NAVB)08-02 19:36

$Navidea生物制药(NAVB)$ DEF 14A Other definitive proxy statements Accession Number: 0001437749-21-018064 Act: 34 Size: 626 KB 网页链接查看全文

持股变动声明

Navidea生物制药(NAVB)07-27 21:03

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-017568 Size: 4 KB 网页链接查看全文

Navidea生物制药(NAVB)07-27 07:33

$Navidea生物制药(NAVB)$ 内部交易: 2021-07-26,Director,Witter Malcolm G ,买入,15000普通股, $1.70查看全文

首次持股声明

Navidea生物制药(NAVB)07-14 06:42

$Navidea生物制药(NAVB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-21-016871 Size: 2 KB 网页链接查看全文

当期报告

Navidea生物制药(NAVB)07-14 04:21

$Navidea生物制药(NAVB)$ 8-K Current report, items 1.01, 5.02, and 9.01 Accession Number: 0001437749-21-016842 Act: 34 Size: 59 KB 网页链接查看全文

持股变动声明

Navidea生物制药(NAVB)07-08 06:00

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-016596 Size: 4 KB 网页链接查看全文

持股变动声明

Navidea生物制药(NAVB)07-08 06:00

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-016598 Size: 4 KB 网页链接查看全文

持股变动声明

Navidea生物制药(NAVB)07-08 06:00

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-016600 Size: 4 KB 网页链接查看全文

当期报告

Navidea生物制药(NAVB)06-25 04:57

$Navidea生物制药(NAVB)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001437749-21-015554 Act: 34 Size: 36 KB 网页链接查看全文

Navidea生物制药(NAVB)06-15 23:51

$Navidea生物制药(NAVB)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-21-081310 Act: 34 Size: 54 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Navidea生物制药的公告

$Navidea生物制药(NAVB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-09 AccNo: 0001437749-19-009295 Size: 5 MB 网页链接

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-04-26 AccNo: 0001437749-19-008036 Size: 31 KBItem 3.03: Material Modifications to Rights of Security HoldersItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Stateme...

$Navidea生物制药(NAVB)$ 美东时间 2019-04-26 拆合股: 20合1 网页链接

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-04-19 AccNo: 0001437749-19-007613 Size: 42 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 3.03: Material Modifications to Rights of Security HoldersI...

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-04-08 AccNo: 0001437749-19-006744 Size: 48 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 9.01: Financial Statements and Exhibits 网页链接

$Navidea生物制药(NAVB)$ 内部交易: 2019-03-22,10% Owner,Scott John K Jr. ,买入,357143普通股, $0.14

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-03-25 AccNo: 0001437749-19-005549 Size: 40 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$Navidea生物制药(NAVB)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-15 AccNo: 0001437749-19-005086 Size: 11 MB 网页链接

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-03-07 AccNo: 0001437749-19-004334 Size: 191 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-02-21 AccNo: 0001437749-19-003001 Size: 23 KBItem 8.01: Other Events 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32